ASH 2022: Hematopoietic Stem Cell Transplantation Use for AML Remains Low Worldwide, Despite Increasing Rates
Findings indicate low rate persisted in regions dominated by high-resource countries
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.